Healmax TV

Market signal

Healmax TV has the most mismatched entity information in this batch. Its iOS seller is HEALMAX BIOMEDICAL RESEARCH INC — a name pointing to biomedical research, entirely unrelated to short drama. On Google Play the same-named listing (package com.healtv.tv) shows a developer address at 150 E Colorado Blvd Ste 100, Pasadena, CA 91105-3831, United States, a personal mailbox healmax999@gmail.com, and a Chinese mobile number +86 193 7488 0924, under the same developer name. So both stores carry the same name while differing in jurisdiction, email type and contact structure — a US address paired with a Chinese phone number is itself a multi-layer entity signature. On scale, AppInsider records under 10,000 cumulative iOS installs, 10K+ on Google Play and roughly 1,000 daily downloads. The iTunes Lookup API returns a rating of 0 with 0 ratings for the US storefront, MWM records 1.1 stars from 15 ratings, and FoxData records 1.33. A product with essentially no US ratings and sub-10,000 total installs is closer to a buying test than a formed business.

Product & content format

On content format, Healmax TV is a vertical short-drama platform whose store copy describes a few-minute episode format across four listed genres: high-energy reversal, sweet romance, suspense and brain teasers. High-energy reversal and sweet romance are direct translations of Chinese web-novel short-drama genre labels, with no locally produced genre described. There is no uniform public standard for episode count or duration. Monetisation is pure subscription: the description explicitly references discounted subscription functions, and FoxData records 10 in-app purchase items. Two translation artefacts are worth noting. The iOS copy reads "A very beautiful and rapidly updated short film application" and "contracts your fragmented time" — the latter almost certainly translating a Chinese original meaning it seizes your fragmented time. The iTunes Lookup API measures a 17+ content rating while Google Play marks it Rated for 3+, a fourteen-level discrepancy between the two stores. The privacy policy is hosted at healmaxbiomedical.com — the same domain as the biomedical company name, further confirming the mismatch between the entity name and the actual business. The terms of use in the App Store description point straight at Apple's standard EULA with no first-party text.

Key figures

Company background

Healmax TV's entity information is clearly mismatched and must be stated as such. The iOS seller is HEALMAX BIOMEDICAL RESEARCH INC, a name pointing to biomedical research with no relation to short drama. On Google Play the same-named app (com.healtv.tv) gives the same developer name but an address at 150 E Colorado Blvd Ste 100, Pasadena, CA 91105-3831, a personal mailbox healmax999@gmail.com, and a Chinese mobile number +86 193 7488 0924. The two stores therefore differ in jurisdiction, email type and contact structure, and the privacy policy is hosted at healmaxbiomedical.com — a domain matching the company name yet pointing to a biomedical business, strongly suggesting either a short-drama line inside an existing biomedical-named entity or a short-drama operation borrowing an existing company's identity. It should be noted that 150 E Colorado Blvd Suite 100 is a commercial address shared by many Pasadena companies and cannot serve as an entity identifier, while the +86 number and personal mailbox indicate operational contact pointing into mainland China. The batch file's designation of the mainland entity as undisclosed still stands: no confirmable mainland operating entity name was found this round, nor any registration state, number or directors for HEALMAX BIOMEDICAL RESEARCH INC. An App Store search also shows another app under the same entity, abShort (id 6757791732, launched 26 March 2026, 0 ratings), whose Android package com.healtv.ab now returns 404 — indicating either an app-matrix layout or a delisted listing.

Competitor scan

• MoboReelsDirect competitor

  CHANGDU (HK) TECHNOLOGY LIMITED

  Also an early-stage product with sub-100,000 installs and weak ratings, but structurally different. MoboReels shows 10M+ installs and 4.2 stars on Google Play, a mature scale; Healmax TV shows 10K+ installs and under 1.5 stars, a testing-stage scale. The two overlap heavily on genre — romance, CEO power-play, sweet romance and suspense dubbed web-novel short drama with no local differentiation — so competition happens purely at the buying layer. Healmax TV's roughly 1,000 daily downloads reflect test-scale media procurement, not ShortMax-style scaled buying.

• abShortSame-company product

  HEALMAX BIOMEDICAL RESEARCH INC

  Another app under the same iOS developer account and the most direct evidence of its matrix strategy. abShort (id 6757791732) launched 26 March 2026 and returns 0 ratings from the iTunes Lookup API, matching its sibling Healmax TV's zero-rating state; its Android package com.healtv.ab now returns 404 on Google Play. Two apps launched in June 2025 and March 2026, both at zero ratings, indicate a multi-app parallel testing approach to the short-drama business.

• MiraluneIndirect competitor

  Hong Kong JoyShow Peaks Network Technology Limited

  Both are sub-100,000-install paid short-drama products launched in the first half of 2026 with ratings in the same low band. The difference is structural: Miralune runs pure subscription with explicit pricing of $14.99 weekly and $39.99 monthly, while Healmax TV's copy mentions only discounted subscription functions with no disclosed tier, making it less price-transparent. At the buying layer the two may compete directly as undifferentiated dubbed-product peers.

User acquisition

Healmax TV has disclosed no user-acquisition data: no channel-level spend, creative volume, ROI or creative library. Two indirect signals exist. First, AppInsider records 500+ daily iOS downloads and 10K+ Google Play installs, test-scale traffic procurement, while third-party rankings give it a composite score of 1.0 at rank 68 with coverage of just one market, confirming extremely narrow buying. Second, the Google Play listing offers no social accounts or ad creative links, and the developer lists only a personal mailbox and address, so creatives cannot be traced from official channels. Notably, no DataEye, Sensor Tower or AppMagic campaign record specific to this product was obtained this round — itself informative: a product at roughly 1,000 daily downloads and near-zero ratings has not yet entered the coverage of mainstream third-party monitoring. Combined assessment: extremely low, undisclosed buying intensity, consistent with remaining in small-scale testing.

KOL & social

No official social account matrix or KOL partnership has been disclosed for Healmax TV. The Google Play developer panel lists only a personal mailbox, an address and a phone number, with no Facebook, Instagram, YouTube or TikTok accounts. The App Store seller page points to healmaxbiomedical.com, a biomedical domain unrelated to short drama and therefore not a marketing property. Healmax TV appears nowhere in English short-drama review ecosystems — with zero US ratings, not even in-store word of mouth has formed, let alone influencer promotion. Combined assessment: its promotion channels are unknown; this section records no public signal.

Hypothesis test

Hypothesis: Healmax TV is not a short-drama company's product but a low-cost white-label test run by an existing biomedical-named entity or an address borrower, and the combination of abnormal ratings, scale and compliance disclosure supports this over a serious short-drama operation. Supporting evidence. First, the mismatch between entity and business is verifiable: the seller is HEALMAX BIOMEDICAL RESEARCH INC, the privacy policy sits at healmaxbiomedical.com, and the actual product is a short-drama content platform — two of three elements unrelated. Second, the registered address at 150 E Colorado Blvd Ste 100 is a commercial address shared by many Pasadena companies, paired with a personal mailbox and a +86 Chinese mobile number — a typical low-cost entity structure rather than the compliance setup of a substantive short-drama company. Third, the product profile fits a test: zero US ratings per the iTunes Lookup API, 10K+ Google Play installs, roughly 1,000 daily downloads, coverage of one market, plus another zero-rating app (abShort) under the same entity. Counter-evidence: a one-off white-label test would not show sustained iteration — iOS has reached 2.0.3 with a July 2026 update and Android was updated in June 2026, indicating at least a year of ongoing investment. And the 17+ versus 3+ split may not be carelessness but a deliberate choice to widen Google Play market coverage, which is a strategic decision rather than pure operational sloppiness. Falsification test: if later versions correct the rating and copy, or launch locally produced content with ratings improving, the case for a legitimate operator strengthens. If the status quo holds with flat scale, the white-label reading stands. Combined verdict: partially confirmed — the low-cost multi-layer entity and test profile hold, but continued iteration shows investment did not stop.

Recent coverage

• healmax (Google Play listing and developer panel)Google Play listing (com.healtv.tv, page HTML fetched directly) · Updated 8 June 2026, fetched 14 Oct 2026 · Verified

  The page shows the app name healmax, developer HEALMAX BIOMEDICAL RESEARCH INC, 10K+ installs, Rated for 3+, in-app purchases, updated 8 June 2026. The developer panel lists email healmax999@gmail.com, address 150 E Colorado Blvd Ste 100 Pasadena CA 91105-3831 United States, phone +86 193 7488 0924. The data safety declaration states no data shared with third parties, possible collection of financial info and device or other IDs, and encryption in transit. A privacy policy link is provided, pointing to the healmaxbiomedical.com domain.

• Healmax TV app page (iOS third-party records)MWM app page and FoxData mobile app report · Jun to Jul 2026 snapshots · Estimated

  MWM records Healmax TV as published by HEALMAX BIOMEDICAL RESEARCH INC, with 5k+ downloads, an App Store rating of 1.1 from 15 ratings, daily updates, and features summarised as one-minute compact episodes, four genres (high-energy reversal, sweet romance, suspense), daily new releases, proprietary original IP and discounted subscription. FoxData records a 1.33 rating, tags for short video, short drama and photo/video, support for 2 languages, 10 in-app purchases and a last update of 1 July 2026. All three records place it in the lowest rating band of this batch.

• Paid short-drama overseas competitor daily, 30 September 2026narku.com short-drama overseas competitor daily · 2026-09-30 · Unverified

  In that issue Healmax TV ranked 68th with a composite score of 1.0 and coverage of one market, attributed to HEALMAX BIOMEDICAL RESEARCH with the mainland entity marked undisclosed. The same table included ZipTale at rank 61, Story TV at rank 70 and Miralune at rank 60, placing Healmax TV in the tail of the ranking. The ranking is third-party compiled material, and its undisclosed-mainland-entity note matches this round's findings.

• App Store search result showing abShort under the same entityiTunes Lookup API search results · Queried 14 Oct 2026 · Verified

  A search for HEALMAX BIOMEDICAL RESEARCH INC as seller returns at least two apps: Healmax TV (id 6745604365) and abShort (id 6757791732, launched 26 March 2026). The iTunes Lookup API measures abShort at 0 ratings from 0 reviews, matching Healmax TV's zero-rating US state. A Google Play reachability check on abShort's package com.healtv.ab returns 404, indicating that listing is no longer accessible on Android.

Industry read

Healmax TV illustrates an edge phenomenon in overseas short drama: low-cost white-label testing still has room to exist in 2026 but has become hard to see in mainstream monitoring. DataEye's January 2026 figures frame this: overseas advertising microdrama apps numbered 905, down 18% month over month, with the ad-supported cohort falling from 515 to 405 (a 21% drop) while the in-app-purchase cohort slipped only from 78 to 72. Pure paid products therefore survive a shakeout better — but the precondition is that reputation and the paid experience hold up. Healmax TV sits on the other side: zero US ratings, 10K+ installs, single-market coverage and a fourteen-level rating gap between stores. The counterpoint from the top: first-half 2026 revenue of $195.35 million for DramaBox, $188.46 million for ReelShort and $128.09 million for NetShort, with ReelShort achieving quarterly profit for the first time. The paid track's ceiling is intact, but its distribution is highly concentrated. For Healmax TV the problem is not whether it can enter this market but whether it has any verifiable differentiation.